1. P194 Epivin: a phase II double-blind randomised control trial investigating the use of epigallocatechin-3-gallate (veregen®, catephen®) vs placebo in the treatment of usual-typed vulval intraepithelial neoplasia. (1st November 2019) Authors: Yap, J; Slade, D; Fox, R; Kaur, B; Hughes, A; Ganesan, R; Velangi, S; Luesley, D Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Sinecatechins ointment as a potential novel treatment for usual type vulval intraepithelial neoplasia: a single‐centre double‐blind randomised control study. (8th November 2020) Authors: Yap, J; Slade, D; Goddard, H; Dawson, C; Ganesan, R; Velangi, S; Sahu, B; Kaur, B; Hughes, A ; Luesley, D Journal: BJOG Issue: Volume 128:Number 6(2021) Page Start: 1047 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗